ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011